BRIEF published on 10/24/2025 at 08:05, 5 months 25 days ago Partial approval of the resolutions by the Vergnet General Assembly Shareholders Renewable Energies Resolutions General Assembly Vergnet
BRIEF published on 10/24/2025 at 07:59, 5 months 25 days ago ONWARD Medical Secures Over EUR 50 Million in Capital Increase Capital Increase Neurotechnology EUR 50 Million ONWARD Medical Spinal Cord Injury
BRIEF published on 10/24/2025 at 07:51, 5 months 25 days ago Wendel's Strategic Moves in Q3 2025 Net Asset Value IK Partners Wendel Investment Committed Advisors Iron Wave
BRIEF published on 10/24/2025 at 07:49, 5 months 25 days ago Ottobock Strengthens Investment in NeuroTech Company ONWARD® Medical Ottobock ONWARD Medical ARC-EX System Spinal Cord Injury NeuroTech Investment
BRIEF published on 10/24/2025 at 07:35, 5 months 25 days ago Circus SE Fortifies Position with New Defense Patents AI Robotics Technological Sovereignty Defense Patents Culinary Autonomy Competitive Barrier
BRIEF published on 10/24/2025 at 07:10, 5 months 25 days ago LEPAS Fun Test Drive Showcases Intelligent Driving Innovations Intelligent Driving Chery Group Elegant Technology LEPAS Fun Test Drive User Co-Creation
BRIEF published on 10/24/2025 at 07:05, 5 months 25 days ago BB Biotech AG Releases Interim Report Highlighting Significant Profit Increase Investment Company BB Biotech AG Interim Report Net Profit Increase Drug Developers
BRIEF published on 10/24/2025 at 07:05, 5 months 25 days ago BB Biotech's Q3 2025 Outperformance Amid Sector Recovery Sector Recovery BB Biotech Q3 2025 Performance Nasdaq Biotechnology Index RNA-based Therapeutics
BRIEF published on 10/24/2025 at 07:05, 5 months 25 days ago Safran's Strong Q3 Performance and Raised 2025 Outlook 2025 Financial Outlook Safran Revenue Growth Civil Engine Aftermarket LEAP Engine Deliveries Acquisitions Integration
BRIEF published on 10/24/2025 at 07:04, 5 months 25 days ago Relief Therapeutics Schedules Extraordinary General Meeting for Business Merger Business Combination Extraordinary General Meeting Relief Therapeutics MindMaze Therapeutics NeuroX Group
Published on 04/18/2026 at 04:00, 5 hours 11 minutes ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 7 hours 11 minutes ago AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 7 hours 36 minutes ago Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 8 hours 11 minutes ago Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 9 hours 11 minutes ago Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Published on 04/18/2026 at 00:05, 9 hours 6 minutes ago ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 20:33, 12 hours 37 minutes ago LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:30, 13 hours 41 minutes ago KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 19:29, 13 hours 42 minutes ago EQS-Adhoc: KAP AG: KAP AG: REFINANCING CONCEPT AGREED; TERM OF EXISTING SYNDICATED LOAN EXTENDED BY THREE YEARS
Published on 04/17/2026 at 19:00, 14 hours 11 minutes ago Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 15 hours 26 minutes ago Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 15:26, 17 hours 45 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of March 31, 2026
Published on 04/17/2026 at 09:10, 1 day ago Number of shares and voting rights - March 2026 (In French only)
Published on 04/16/2026 at 18:02, 1 day 15 hours ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
